ArticleAnimal models and experimental medicine2026
Source-dependent variability in gut barrier disruption, bacterial translocation, and immune activation after ischemic stroke in Wistar rats.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Stroke induces profound neuroinflammation and systemic immune dysregulation, including disturbances in gut homeostasis. Experimental evidence suggests that intestinal barrier permeability (IBP) and bacterial translocation (BT) critically influence stroke outcomes. However, biological variability among commonly used rodent substrains has received limited attention. In this pilot study, we compared poststroke immune responses in two Wistar rat substrains obtained from different suppliers: RccHan (Envigo) and RjHan (Janvier). Naive animals (n = 4) and rats subjected to permanent cerebral ischemia (n = 8 per substrain) were evaluated 72 h after middle cerebral artery occlusion and stratified according to the presence or absence of BT. Immune cell populations in blood and bone marrow were analyzed using flow cytometry, and leukocyte infiltration into ischemic brain tissue was quantified using immunohistochemistry. Differences were considered statistically significant when p < 0.05. Both substrains developed significant infarcts and neurological deficits. RccHan rats exhibited larger infarct volumes and more extensive BT across multiple organs. In contrast, RjHan rats exhibited BT mainly confined to mesenteric lymph nodes but exhibited greater IBP. Although dissemination was broader in RccHan rats, overall bacterial burden was slightly lower compared with RjHan, and extraintestinal bacterial composition differed between groups. Particularly, RjHan rats exhibited stronger systemic and central immune activation, with significant alterations in lymphocyte and monocyte populations and enhanced granulocyte and T-cell infiltration within ischemic lesions. These findings demonstrate that substrain origin profoundly influences poststroke intestinal barrier integrity, bacterial dissemination, and immune responses considering substrain-related variability is essential to improve reproducibility and translational relevance in preclinical stroke research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.